Dr. Emmanuel Antonarakis provides an update on treating chemo-naive metastatic hormone sensitive prostate cancer and then discusses the impact of AR-V7 in castration resistant prostate cancer.

Keywords: AR-V7, Castration Resistant Prostate Cancer